With reference to its letter dated August 05, 2021. In compliance with Regulation 33 of the Listing Regulations, Albert David has informed that it enclosed the following; The Unaudited Financial Results for the quarter ended June 30, 2021 (‘Results’) and The Limited Review Report on the aforesaid Results, issued by Basu Chanchani & Deb, Chartered Accountants (FRN: 304049E), Statutory Auditors of the Company. The said Results was recommended by the Audit Committee and approved by the Board of Directors at their respective meetings held today August 12, 2021. The Limited Review Report was also adopted by the Board at the said meeting. All other agenda items were approved in the meeting. The Board Meeting commenced at 02.20 pm and concluded at 03.10 pm.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1862.15 |
| Dr. Reddys Labs. | 1350.00 |
| Cipla | 1440.30 |
| Zydus Lifesciences | 1101.50 |
| Lupin | 2342.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: